How the ERA-MBT roadmap
supports processes and products
Paris
Greensea
The ERA-Net marine Biotechnology 12 oct 2016 Jean-Paul Cadoret
GREENSEAOriginal molecules
APC
Asthaxanthine
DHA
Jean-Paul CadoretThe ERA-Net marine Biotechnology 12 oct 2016
Applications
Animal nutrition
OystersFishesCrustaceansPoultryPorcs
Cosmetics
Skinn careHair cares
Human nutrition
SpirulineDiatomChlorella
Nutraceuticals
PUFAs DHA, EPA, AA
Health
AntiradicalsExopolysaccharidsAntiproliferativesAntiviralsCell factory
Energy
HydrogenBiodieselBiogaz
Environment
Carbon captureDepollutionRemediation
Industry
ColorsEnzymesAdhesivesFltration
Jean-Paul CadoretThe ERA-Net marine Biotechnology 12 oct 2016
GREENTECH BIOTECHNOLOGIES
MARINE WORLDMicro - and Macroalgae
MICROBIAL WORLDBacteria – Yeast - Fungi
PLANT KINGDOM
A SYNERGY of companies dedicated to natural active ingredients
Countless opportunities for Natural active ingredient development
Jean-Paul CadoretThe ERA-Net marine Biotechnology 12 oct 2016
Our group
A sales force
A quality and reglementary department
A weight in Reasearch & development
A global synergy
110 people
TU = 25 Millions
The ERA-Net marine Biotechnology 12 oct 2016
A choice of strategy
Integrated in House deveopment: From the algae to the product
Intensive et qualitative - vs - Extensive et quantitative
Extensive et quantitative : Alliances at the eurouropean level
An important R&D activity
Animal nutrition
OystersFishesCrustaceansPoultryPorcs
Cosmetics
Human nutrition
SpirulineDiatomChlorella
Pigments
MedicalFood colorationCosmetics
Health
AntiradicalsExopolysaccharidsAntiproliferativesAntiviralsCell factory
Industry
ColorsEnzymesAdhesivesFltration
Jean-Paul Cadoret
A choice of strategy
The ERA-Net marine Biotechnology 12 oct 2016
SILIDINE®
Vascular tonicity enhancement
Produits phares en cosmétique
Jean-Paul CadoretThe ERA-Net marine Biotechnology 12 oct 2016
SILIDINE® - Clinical StudyDoppler effect evaluation
SILIDINE® 1% (powder form) improves the vascular tonicity and helps to decrease heavy legs syndrome
Jean-Paul CadoretThe ERA-Net marine Biotechnology 12 oct 2016
P. cruentum subjected to oxidative stress: an innovative cosmetic active for vascular tonicity enhancement
INCI Name SILIDINE®: Water, Porphyridium cruentum exsuded culture medium
Common inflammatory facial
dermatoses
Chronic condition
Facial erythema
Excessive vasodilatation
Affects 45 million people worldwide!
SILIDINE® 3% tested on volunteers with rosacea
-1%
-19%-20%
-15%
-10%
-5%
0%
Faci
al r
edn
ess
red
uct
ion
(%
)
Placebo SILIDINE® 3%
**p<0,05
Silidine® significantly decreases by 19% facial redness
Jean-Paul CadoretThe ERA-Net marine Biotechnology 12 oct 2016
Decrease in facial redness of the volunteers after 28 days of twice daily-use of the two formulations
Day 28
SILIDINE® 3%
Placebo
Day 0
-26%
-6%
Volunteer 14
Jean-Paul CadoretThe ERA-Net marine Biotechnology 12 oct 2016